Wainwright

HC Wainwright Reaffirms Hold Rating for Syros Pharmaceuticals (NASDAQ:SYRS) - Slater Sentinel
HC Wainwright Reaffirms Hold Rating for Syros Pharmaceuticals (NASDAQ:SYRS) - Slater Sentinel
Marinus Pharmaceuticals (NASDAQ:MRNS) Rating Reiterated by HC Wainwright - Trent Times
Marinus Pharmaceuticals (NASDAQ:MRNS) Rating Reiterated by HC Wainwright - Trent Times
Pluristem Therapeutics (NASDAQ:PSTI) Earns Buy Rating from HC Wainwright - Slater Sentinel
Pluristem Therapeutics (NASDAQ:PSTI) Earns Buy Rating from HC Wainwright - Slater Sentinel
Forty Seven (NASDAQ:FTSV) Rating Reiterated by HC Wainwright - DFS Caller
Pretium Resources (TSE:PVG) Stock Rating Reaffirmed by HC Wainwright - Trent Times
Pretium Resources (TSE:PVG) Stock Rating Reaffirmed by HC Wainwright - Trent Times
Livexlive Media (NASDAQ:LIVX) Rating Reiterated by HC Wainwright - Mitchell Messenger
Livexlive Media (NASDAQ:LIVX) Rating Reiterated by HC Wainwright - Mitchell Messenger
Hookipa Pharma (NASDAQ:HOOK) Stock Rating Reaffirmed by HC Wainwright - Mitchell Messenger
Hookipa Pharma (NASDAQ:HOOK) Stock Rating Reaffirmed by HC Wainwright - Mitchell Messenger
Cellectar Biosciences (NASDAQ:CLRB) Stock Rating Reaffirmed by HC Wainwright - Trent Times
Cellectar Biosciences (NASDAQ:CLRB) Stock Rating Reaffirmed by HC Wainwright - Trent Times
Vascular Biogenics (NASDAQ:VBLT) Given “Buy” Rating at HC Wainwright - Mitchell Messenger
Vascular Biogenics (NASDAQ:VBLT) Given “Buy” Rating at HC Wainwright - Mitchell Messenger
HC Wainwright Reiterates “Hold” Rating for Syros Pharmaceuticals (NASDAQ:SYRS) - Slater Sentinel
HC Wainwright Reiterates “Hold” Rating for Syros Pharmaceuticals (NASDAQ:SYRS) - Slater Sentinel
Seattle Genetics (NASDAQ:SGEN) Rating Reiterated by HC Wainwright - Slater Sentinel
Seattle Genetics (NASDAQ:SGEN) Rating Reiterated by HC Wainwright - Slater Sentinel
Forty Seven (NASDAQ:FTSV) Given “Buy” Rating at HC Wainwright - Riverton Roll
Forty Seven (NASDAQ:FTSV) Given “Buy” Rating at HC Wainwright - Riverton Roll
Tetraphase Pharmaceuticals (NASDAQ:TTPH) Receives “Hold” Rating from HC Wainwright - Mitchell Messenger
Tetraphase Pharmaceuticals (NASDAQ:TTPH) Receives “Hold” Rating from HC Wainwright - Mitchell Messenger
First Majestic Silver (NYSE:AG) Receives Buy Rating from HC Wainwright - Slater Sentinel
First Majestic Silver (NYSE:AG) Receives Buy Rating from HC Wainwright - Slater Sentinel
Asanko Gold (NYSEAMERICAN:AKG) Rating Reiterated by HC Wainwright - Mitchell Messenger
Asanko Gold (NYSEAMERICAN:AKG) Rating Reiterated by HC Wainwright - Mitchell Messenger
Stealth BioTherapeutics (NASDAQ:MITO) Rating Reiterated by HC Wainwright - Trent Times
Stealth BioTherapeutics (NASDAQ:MITO) Rating Reiterated by HC Wainwright - Trent Times
The Times view on Alfred Wainwright: Walk On - The Times
The Times view on Alfred Wainwright: Walk On - The Times
Give Alfred Wainwright's trail the status it deserves - The Times
Give Alfred Wainwright's trail the status it deserves - The Times
Alfred Wainwright's unfinished coastal walks (that he went to by car) - The Times
Alfred Wainwright's unfinished coastal walks (that he went to by car) - The Times
Rubius Therapeutics (NASDAQ:RUBY) Rating Reiterated by HC Wainwright - Riverton Roll
Rubius Therapeutics (NASDAQ:RUBY) Rating Reiterated by HC Wainwright - Riverton Roll
Aravive’s (ARAV) “Buy” Rating Reaffirmed at HC Wainwright - Riverton Roll
Aravive’s (ARAV) “Buy” Rating Reaffirmed at HC Wainwright - Riverton Roll
HC Wainwright Cuts Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target to $18.00 - Trent Times
HC Wainwright Cuts Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target to $18.00 - Trent Times
Americas Silver (NYSEAMERICAN:USAS) Stock Rating Reaffirmed by HC Wainwright - Trent Times
Americas Silver (NYSEAMERICAN:USAS) Stock Rating Reaffirmed by HC Wainwright - Trent Times
HC Wainwright Reiterates Buy Rating for General Moly (NYSEAMERICAN:GMO) - DFS Caller
Leap Therapeutics (NASDAQ:LPTX) Given Buy Rating at HC Wainwright - DFS Caller
Pulmatrix (NASDAQ:PULM) Given Buy Rating at HC Wainwright - Mitchell Messenger
Pulmatrix (NASDAQ:PULM) Given Buy Rating at HC Wainwright - Mitchell Messenger
HC Wainwright Increases Amicus Therapeutics (NASDAQ:FOLD) Price Target to $20.00 - Riverton Roll
HC Wainwright Increases Amicus Therapeutics (NASDAQ:FOLD) Price Target to $20.00 - Riverton Roll
Edap Tms (NASDAQ:EDAP) Rating Reiterated by HC Wainwright - Slater Sentinel
Edap Tms (NASDAQ:EDAP) Rating Reiterated by HC Wainwright - Slater Sentinel
Turning Point Therapeutics (NASDAQ:TPTX) Rating Reiterated by HC Wainwright - Mitchell Messenger
Turning Point Therapeutics (NASDAQ:TPTX) Rating Reiterated by HC Wainwright - Mitchell Messenger
Amicus Therapeutics (NASDAQ:FOLD) Given New $20.00 Price Target at HC Wainwright - Riverton Roll
Amicus Therapeutics (NASDAQ:FOLD) Given New $20.00 Price Target at HC Wainwright - Riverton Roll
Palatin Technologies' (PTN) Buy Rating Reiterated at HC Wainwright - DFS Caller
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Stock Rating Reaffirmed by HC Wainwright - DFS Caller
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Rating Reiterated by HC Wainwright - Slater Sentinel
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Rating Reiterated by HC Wainwright - Slater Sentinel
HC Wainwright Analysts Give Principia Biopharma (NASDAQ:PRNB) a $57.00 Price Target - Mitchell Messenger
HC Wainwright Analysts Give Principia Biopharma (NASDAQ:PRNB) a $57.00 Price Target - Mitchell Messenger
Americas Silver (NYSEAMERICAN:USAS) Receives “Buy” Rating from HC Wainwright - Slater Sentinel
Americas Silver (NYSEAMERICAN:USAS) Receives “Buy” Rating from HC Wainwright - Slater Sentinel
Largo Resources (OTCMKTS:LGORF) Receives Buy Rating from HC Wainwright - Mitchell Messenger
Largo Resources (OTCMKTS:LGORF) Receives Buy Rating from HC Wainwright - Mitchell Messenger
HC Wainwright Reiterates “Positive” Rating for Balchem (NASDAQ:BCPC) - Mitchell Messenger
HC Wainwright Reiterates “Positive” Rating for Balchem (NASDAQ:BCPC) - Mitchell Messenger
HC Wainwright Raises Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $36.00 - Mitchell Messenger
HC Wainwright Raises Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $36.00 - Mitchell Messenger
Strongbridge Biopharma (NASDAQ:SBBP) Rating Reiterated by HC Wainwright - Mitchell Messenger
Strongbridge Biopharma (NASDAQ:SBBP) Rating Reiterated by HC Wainwright - Mitchell Messenger
HC Wainwright Lowers Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target to $18.00 - Mitchell Messenger
HC Wainwright Lowers Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target to $18.00 - Mitchell Messenger
HC Wainwright Reaffirms “Buy” Rating for CymaBay Therapeutics (NASDAQ:CBAY) - Trent Times
HC Wainwright Reaffirms “Buy” Rating for CymaBay Therapeutics (NASDAQ:CBAY) - Trent Times
Acceleron Pharma's (XLRN) Buy Rating Reiterated at HC Wainwright - Livingston Ledger
DRDGOLD (NYSE:DRD) Earns Buy Rating from HC Wainwright - Riverton Roll
DRDGOLD (NYSE:DRD) Earns Buy Rating from HC Wainwright - Riverton Roll
Zynex (OTCMKTS:ZYXI) Given “Buy” Rating at HC Wainwright - Slater Sentinel
Zynex (OTCMKTS:ZYXI) Given “Buy” Rating at HC Wainwright - Slater Sentinel
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Rating Lowered by HC Wainwright - Stock News Brief
Pieris Pharmaceuticals (NASDAQ:PIRS) Stock Rating Reaffirmed by HC Wainwright - DFS Caller
Interpace Diagnostics Group’s (IDXG) “Buy” Rating Reaffirmed at HC Wainwright - Mitchell Messenger
Interpace Diagnostics Group’s (IDXG) “Buy” Rating Reaffirmed at HC Wainwright - Mitchell Messenger
Neovasc (NASDAQ:NVCN) Coverage Initiated by Analysts at HC Wainwright - Mitchell Messenger
Neovasc (NASDAQ:NVCN) Coverage Initiated by Analysts at HC Wainwright - Mitchell Messenger
Kezar Life Sciences (NASDAQ:KZR) Rating Reiterated by HC Wainwright - Mitchell Messenger
Kezar Life Sciences (NASDAQ:KZR) Rating Reiterated by HC Wainwright - Mitchell Messenger
Alkaline Water (OTCMKTS:WTER) PT Set at $3.00 by HC Wainwright - Slater Sentinel
Alkaline Water (OTCMKTS:WTER) PT Set at $3.00 by HC Wainwright - Slater Sentinel
Desktop versie